Marsha G Raanan

Combining the G‐protein‐coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12‐week trial

C. Cao, J. Marcinak, X. V. Peng, 2017, Diabetes, obesity & metabolism.

Safety and Pharmacodynamics of Lansoprazole in Patients with Gastroesophageal Reflux Disease Aged <1 Year

Marsha G Raanan, M. Springer, S. Atkinson, 2008, Paediatric drugs.

A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate.

R. Rupp, L. Jackson, D. Wallace, 2018, Vaccine.

Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.

Alfonso T. Perez, R. Lindsay, M. McClung, 2013, The Journal of clinical endocrinology and metabolism.

Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study.

D. Stinchcomb, R. Rupp, J. Osorio, 2015, Vaccine.

Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.

S. Orenstein, E. Hassall, Marsha G Raanan, 2009, The Journal of pediatrics.

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial

Vianney Tricou, D. Wallace, A. Borkowski, 2020, Human vaccines & immunotherapeutics.

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.

L. Shek, I. Velez, D. Stinchcomb, 2016, The Journal of infectious diseases.